Summary
A 38-year-old engineer employed by a defense contractor was granted a security clearance despite concerns under Guideline E (Personal Conduct) and Guideline H (Drug Involvement). The Statement of Reasons alleged a history of marijuana use from approximately July 2004 through at least September 2019, including use after being granted a security clearance in September 2010. Additionally, the applicant was alleged to have engaged in questionable judgment, lack of candor, and dishonesty related to his drug use.
Disqualifying conditions H.25.a, H.25.f, and E.16.c were raised. However, the administrative judge applied mitigating conditions H.26.a, H.26.b, and E.17.c. The judge found that the applicant demonstrated a clear understanding of security clearance rules regarding drug use and provided credible evidence of abstaining from illegal drug use since August 2019.
The decision highlighted that the applicant's past drug use was infrequent and occurred under unusual circumstances. Ultimately, the applicant's eligibility for access to classified information was GRANTED, as he successfully mitigated security concerns by demonstrating a commitment to abstain from illegal drug use.
Why the Applicant Prevailed
- The applicant demonstrated a clear understanding of security clearance rules regarding drug use.
- The applicant provided credible evidence of abstaining from illegal drug use since August 2019.
- The applicant's past drug use was infrequent and occurred under unusual circumstances.
Conditions Referenced
- H.25.araisedSubstance Misuse
- H.25.fraisedIllegal Drug Use While Holding a Security Clearance
- E.16.craisedCredible Adverse Information
- H.26.aappliedBehavior Unlikely to Recur
- H.26.bappliedAcknowledgment of Drug Involvement and Pattern of Abstinence
- E.17.cappliedMinor Offense or Unlikely to Recur
Key Rule Quoted
“The protection of the national security is the paramount consideration.”
Procedural Posture
- SOR issuedJan 4, 2021
- Answer filedJan 22, 2021
- Hearing heldMar 16, 2022via video teleconference
- Decision dateMay 2, 2022
Cite For
- Mitigation of Drug Involvement Under Guideline H
- Understanding of Security Clearance Rules as a Mitigating Factor
- Whole-person Assessment in Security Clearance Decisions